Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Bipolar Disorders Topic Center

Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
Delusion Themes Stay Consistent Across Psychosis Episodes
News
Delusion Themes Stay Consistent Across Psychosis Episodes, Study Finds
08/20/2024
Delusion content was similar across episodes of psychosis in patients who relapsed over a 2-year naturalistic course of care, according to a study published in JAMA Psychiatry. 
Delusion content was similar across episodes of psychosis in patients who relapsed over a 2-year naturalistic course of care, according to a study published in JAMA Psychiatry. 
Delusion content was similar...
08/20/2024
Psych Congress Network
fda
News
FDA Approves Iloperidone for Acute Treatment of Bipolar I Disorder
04/08/2024
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
News
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
03/26/2024
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode...
03/26/2024
Psych Congress Network
Young Adults Who Self-Harm May Be More at Risk of Psychosis Diagnosis
News
Young Adults Who Self-Harm May Be More at Risk of Psychosis Diagnosis
02/27/2024
Young adults and teenagers who presented to the hospital with self-harm were found to be more likely to receive a psychotic disorder diagnosis later in life, according to recent findings from a cohort study published in the journal...
Young adults and teenagers who presented to the hospital with self-harm were found to be more likely to receive a psychotic disorder diagnosis later in life, according to recent findings from a cohort study published in the journal...
Young adults and teenagers who...
02/27/2024
Psych Congress Network
Death risk increased by how much with a bipolar disorder diagnosis?
Quiz
Death risk increased by how much with a bipolar disorder diagnosis?
02/26/2024
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/26/2024
Psych Congress Network
Bipolar Disorder Increases Mortality Risk More Than Smoking
News
Bipolar Disorder Increases Mortality Risk More Than Smoking
02/05/2024
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder...
02/05/2024
Psych Congress Network
Brain with puzzle piece missing
News
Vitamin B6 Plus Lithium Helps Ease Mania Symptoms in Patients With Bipolar Disorder
01/03/2024
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive...
01/03/2024
Psych Congress Network
News
Use of Psilocbyin in Bipolar II Treatment Clinical Trial Produces Strong Results
12/12/2023
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by...
12/12/2023
Psych Congress Network
bipolar disorder graphic
News
Metformin Helps Prevent Weight Gain in Youth Taking Medication for Bipolar Disorder
11/15/2023
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug...
11/15/2023
Psych Congress Network
News
FDA Approves ABILIFY ASIMTUFII for Schizophrenia and Bipolar Disorder Treatment
04/28/2023
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY...
04/28/2023
Psych Congress Network

Videos

Phyllis Foxworth
Videos
Closing the Patient-Clinician Gap When Defining Progress and Outcomes in Mood Disorders
05/18/2022
Phyllis Foxworth discusses how clinicians and patients can work together to more closely align their goals and outcomes when treating mood disorders, and explores realistic expectations for treatment and tips for family and friends of...
Phyllis Foxworth discusses how clinicians and patients can work together to more closely align their goals and outcomes when treating mood disorders, and explores realistic expectations for treatment and tips for family and friends of...
Phyllis Foxworth discusses how...
05/18/2022
Psych Congress Network
Phyllis Foxworth DBSA
Videos
Tools to Alleviate Isolation, Life Disruption From COVID-19 in Patients With BD-I
03/25/2022
Phyllis Foxworth addresses how the COVID-19 pandemic has exacerbated feelings of isolation in patients with bipolar 1 disorder (BD-I) and tools for clinicians who are treating these patients.
Phyllis Foxworth addresses how the COVID-19 pandemic has exacerbated feelings of isolation in patients with bipolar 1 disorder (BD-I) and tools for clinicians who are treating these patients.
Phyllis Foxworth addresses how...
03/25/2022
Psych Congress Network
Dr Craig Chepke
Videos
Bipolar Disorder: The Importance of Person-Centered Care
03/04/2022
Craig Chepke, MD, FAPA, shares his key insights and takeaways regarding the burden on people living with bipolar I disorder, especially as it relates to the importance of person-centered care.
Craig Chepke, MD, FAPA, shares his key insights and takeaways regarding the burden on people living with bipolar I disorder, especially as it relates to the importance of person-centered care.
Craig Chepke, MD, FAPA, shares...
03/04/2022
Psych Congress Network
Dr Chepke
Videos
The Impacts of COVID-19 on People With Bipolar Disorder
02/24/2022
Craig Chepke, MD, FAPA, discusses the impact of COVID-19 and the burden on people living with bipolar I disorder, specifically the important topics of isolation, medication trial and error, and stigma.
Craig Chepke, MD, FAPA, discusses the impact of COVID-19 and the burden on people living with bipolar I disorder, specifically the important topics of isolation, medication trial and error, and stigma.
Craig Chepke, MD, FAPA,...
02/24/2022
Psych Congress Network
rakesh jain
Videos
Rakesh Reviews: Predictors of Diagnostic Transition From Major Depressive Disorder to Bipolar Disorder: A Retrospective Observational Network Study
01/10/2022
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club...
01/10/2022
Psych Congress Network
Pharmacogenetic Testing as a Tool in Bipolar Disorder Treatment
Videos
Pharmacogenetic Testing as a Tool in Bipolar Disorder Treatment
04/23/2021
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the utility and limitations of pharmacogenetics in the treatment of bipolar disorders.
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the utility and limitations of pharmacogenetics in the treatment of bipolar disorders.
Bipolar Disorders Section Editor...
04/23/2021
Psych Congress Network
Understanding Polarity-Proneness in Patients With Bipolar Disorder
Videos
Understanding Polarity-Proneness in Patients With Bipolar Disorder
04/23/2021
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the concept of polarity-proneness and why clinicians should assess it when treating patients with bipolar disorder.
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the concept of polarity-proneness and why clinicians should assess it when treating patients with bipolar disorder.
Bipolar Disorders Section Editor...
04/23/2021
Psych Congress Network
Considerations When Making a Bipolar Disorder Treatment Plan
Videos
Considerations When Making a Bipolar Disorder Treatment Plan
04/22/2021
Jessica Whelan, DNP, APRN, FPMHNP-BC reviews the many factors that come in to play when she is developing a treatment plan for her patients with bipolar disorder.
Jessica Whelan, DNP, APRN, FPMHNP-BC reviews the many factors that come in to play when she is developing a treatment plan for her patients with bipolar disorder.
Jessica Whelan, DNP, APRN,...
04/22/2021
Psych Congress Network
Distinguishing Between Bipolar I Disorder and Bipolar II Disorder
Videos
Distinguishing Between Bipolar I Disorder and Bipolar II Disorder
04/21/2021
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains some key distinctions between bipolar I disorder and bipolar II disorder and treatment implications of the differences. 
Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains some key distinctions between bipolar I disorder and bipolar II disorder and treatment implications of the differences. 
Bipolar Disorders Section Editor...
04/21/2021
Psych Congress Network
Bipolar Disorder and the Brain
Videos
Bipolar Disorder and the Brain
03/30/2021
Jessica Whelan, DNP, APRN, FPMHNP-BC discusses the value of understanding the neurobiology behind bipolar disorder and how she explains it to her patients.
Jessica Whelan, DNP, APRN, FPMHNP-BC discusses the value of understanding the neurobiology behind bipolar disorder and how she explains it to her patients.
Jessica Whelan, DNP, APRN,...
03/30/2021
Psych Congress Network
Jonathan Meyer, MD
Videos
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
11/11/2024
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his...
11/11/2024
Psych Congress Network
Desiree Matthews
Schizophrenia Conference Insights
New Class of Medication Offers Innovative Treatment for Schizophrenia Symptoms
11/07/2024
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights...
11/07/2024
Psych Congress Network
Marc Agronin
Videos
Implementing Alzheimer Disease Prevention Practices
11/02/2024
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some...
11/02/2024
Psych Congress Network
Christoph Correll, MD.
Videos
Strategies to Manage Adverse Effects From Schizophrenia Treatment
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers...
10/28/2024
Psych Congress Network
Christoph Correll, MD
Videos
Beyond D2 Receptor Manipulation: Novel Agents for Schizophrenia Treatment
10/16/2024
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides...
10/16/2024
Psych Congress Network
Christoph Correll, MD
Videos
Recognizing the Early Indicators of Schizophrenia
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews...
10/08/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
Best Practices for Prescribing Long-Acting Injectable Medications Via Telehealth
09/30/2024
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO,...
09/30/2024
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network

News Articles

Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
Delusion Themes Stay Consistent Across Psychosis Episodes
News
Delusion Themes Stay Consistent Across Psychosis Episodes, Study Finds
08/20/2024
Delusion content was similar across episodes of psychosis in patients who relapsed over a 2-year naturalistic course of care, according to a study published in JAMA Psychiatry. 
Delusion content was similar across episodes of psychosis in patients who relapsed over a 2-year naturalistic course of care, according to a study published in JAMA Psychiatry. 
Delusion content was similar...
08/20/2024
Psych Congress Network
fda
News
FDA Approves Iloperidone for Acute Treatment of Bipolar I Disorder
04/08/2024
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
News
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
03/26/2024
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode...
03/26/2024
Psych Congress Network
Young Adults Who Self-Harm May Be More at Risk of Psychosis Diagnosis
News
Young Adults Who Self-Harm May Be More at Risk of Psychosis Diagnosis
02/27/2024
Young adults and teenagers who presented to the hospital with self-harm were found to be more likely to receive a psychotic disorder diagnosis later in life, according to recent findings from a cohort study published in the journal...
Young adults and teenagers who presented to the hospital with self-harm were found to be more likely to receive a psychotic disorder diagnosis later in life, according to recent findings from a cohort study published in the journal...
Young adults and teenagers who...
02/27/2024
Psych Congress Network
Bipolar Disorder Increases Mortality Risk More Than Smoking
News
Bipolar Disorder Increases Mortality Risk More Than Smoking
02/05/2024
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder...
02/05/2024
Psych Congress Network
Brain with puzzle piece missing
News
Vitamin B6 Plus Lithium Helps Ease Mania Symptoms in Patients With Bipolar Disorder
01/03/2024
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive...
01/03/2024
Psych Congress Network
News
Use of Psilocbyin in Bipolar II Treatment Clinical Trial Produces Strong Results
12/12/2023
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by Sheppard Pratt researchers, 80% of participants with treatment-resistant bipolar II met the criteria for remission 12 weeks after treatment that included psilocybin and therapy.
In a recent trial conducted by...
12/12/2023
Psych Congress Network
bipolar disorder graphic
News
Metformin Helps Prevent Weight Gain in Youth Taking Medication for Bipolar Disorder
11/15/2023
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug...
11/15/2023
Psych Congress Network
News
FDA Approves ABILIFY ASIMTUFII for Schizophrenia and Bipolar Disorder Treatment
04/28/2023
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY...
04/28/2023
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
News
Add-on Intravenous Racemic Ketamine May be Best for Treatment-Resistant Depression
11/19/2024
Augmentative treatment with intravenous racemic ketamine in adults with treatment-resistant unipolar depression appears to be better than augmentative intranasal esketamine or aripiprazole.
Augmentative treatment with intravenous racemic ketamine in adults with treatment-resistant unipolar depression appears to be better than augmentative intranasal esketamine or aripiprazole.
Augmentative treatment with...
11/19/2024
Psych Congress Network
Acute Care Utilization Lower When Buprenorphine Doses Are Higher
News
Acute Care Utilization Lower When Buprenorphine Doses Are Higher
11/19/2024
US adults with OUD who received buprenorphine at doses higher than recommended by the FDA had lower rates of urgent health care utilization than those whose doses were in line with FDA recommendations.
US adults with OUD who received buprenorphine at doses higher than recommended by the FDA had lower rates of urgent health care utilization than those whose doses were in line with FDA recommendations.
US adults with OUD who received...
11/19/2024
Psych Congress Network
neurology brain stress
News
Targeted Lucidity Reactivation May Help Ease Narcolepsy-Related Nightmares
11/18/2024
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of...
11/18/2024
Neurology
Treatment Discontinuation Rates Lower With Methadone Than Buprenorphine/Naloxone
News
Treatment Discontinuation Rates Lower With Methadone Than Buprenorphine/Naloxone
11/18/2024
Methadone was associated with a lower risk of treatment discontinuation than buprenorphine/naloxone among patients with opioid use disorder, according to study findings published in JAMA.
Methadone was associated with a lower risk of treatment discontinuation than buprenorphine/naloxone among patients with opioid use disorder, according to study findings published in JAMA.
Methadone was associated with a...
11/18/2024
Psych Congress Network
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
Adults Who Smoke Have More Chronic Pain, Use More Opioids
News
Adults Who Smoke Have More Chronic Pain, Use More Opioids
11/15/2024
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain,...
11/15/2024
Psych Congress Network
a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network

Interactive Features

Death risk increased by how much with a bipolar disorder diagnosis?
Quiz
Death risk increased by how much with a bipolar disorder diagnosis?
02/26/2024
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/26/2024
Psych Congress Network
polygenic risk scores
Quiz
Is there an association between hospitalization frequency and polygenic risk score?
10/06/2022
Take the quiz to test your clinical knowledge!
Take the quiz to test your clinical knowledge!
Take the quiz to test your...
10/06/2022
Psych Congress Network
COVID-19 risk.
Quiz
Antipsychotic Use and COVID-19 Risk in Patients with BD and SMI
06/15/2022
How does antipsychotic use affect COVID-19 risk? Take the quiz now to test your knowledge!
How does antipsychotic use affect COVID-19 risk? Take the quiz now to test your knowledge!
How does antipsychotic use...
06/15/2022
Psych Congress Network
Quiz
Challenges for Patients With Bipolar Disorder
01/11/2022
According to a recent survey, which of the following concerns did patients with bipolar-I disorder report?
According to a recent survey, which of the following concerns did patients with bipolar-I disorder report?
According to a recent survey,...
01/11/2022
Psych Congress Network
A doctor looks at a brain scan
Quiz
TBI and Schizophrenia Risk
11/19/2024
Do you know how to care for this patient population? Find out with a quick quiz!
Do you know how to care for this patient population? Find out with a quick quiz!
Do you know how to care for this...
11/19/2024
Psych Congress Network
By how much did drug overdose deaths increase year over year?
Quiz
By how much did drug overdose deaths increase year over year?
11/19/2024
Test your knowledge!
Test your knowledge!
Test your knowledge!
11/19/2024
Psych Congress Network
quiz
Quiz
Key Barriers to Tardive Dyskinesia Diagnosis
11/18/2024
The key barriers to a tardive dyskinesia diagnosis DID NOT include which of the following, according to data presented in a poster at Psych Congress 2024? Take the quiz now!
The key barriers to a tardive dyskinesia diagnosis DID NOT include which of the following, according to data presented in a poster at Psych Congress 2024? Take the quiz now!
The key barriers to a tardive...
11/18/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Expert Insights Quiz
LAIs and Telehealth Psychiatric Care
10/24/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
10/24/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
Adult ADHD Diagnosis Rates
10/23/2024
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
10/23/2024
Psych Congress Network
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
pop quiz
Quiz
Esketamine Dosing Schedule for Treatment-Resistant Depression
10/01/2024
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and...
10/01/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Telehealth Versus In-Person Psychiatric Care
09/19/2024
Do you know what the data from randomized control trials say?
Do you know what the data from randomized control trials say?
Do you know what the data from...
09/19/2024
Psych Congress Network
How many ADHD prescriptions are affected by the med shortage?
Quiz
How many ADHD prescriptions are affected by the med shortage?
09/17/2024
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent...
09/17/2024
Psych Congress Network
Symptom Reduction in Bipolar Disorder Treatment
Expert Insights Quiz
Symptom Reduction in Bipolar Disorder Treatment
09/13/2024
Test your knowledge
Test your knowledge
Test your knowledge
09/13/2024
Psych Congress Network

Blogs

Blog
How to Welcome Incoming Residents: Learning from Tragedy
07/30/2015
This year at orientation, there was a huge elephant in the room.
This year at orientation, there was a huge elephant in the room.
This year at orientation, there...
07/30/2015
Psych Congress Network
Blog
The Gift of Self-Disclosure
02/19/2015
Ode to Dr. Quinn Leslie who has paved the path to accepting non-perfectionism.
Ode to Dr. Quinn Leslie who has paved the path to accepting non-perfectionism.
Ode to Dr. Quinn Leslie who has...
02/19/2015
Psych Congress Network
Blog
Three Clinical Pearls That Enhance My Practice
02/04/2015
Clinical pearls from the Psych Congress annual meeting.
Clinical pearls from the Psych Congress annual meeting.
Clinical pearls from the Psych...
02/04/2015
Psych Congress Network
Blog
How to Minimize Cycling/Switching in Patients with Bipolar Disorder
11/11/2014
Bipolar disorder affects approximately 2% to 3% of the population and is the sixth leading cause of disability worldwide.
Bipolar disorder affects approximately 2% to 3% of the population and is the sixth leading cause of disability worldwide.
Bipolar disorder affects...
11/11/2014
Psych Congress Network
Blog
The Nexus of Science and Soul: Forming a Life Narrative After Mental Illness
08/18/2014
To have experienced delusions, psychosis, and suicidal ideation is to be Undermined by one’s self.
To have experienced delusions, psychosis, and suicidal ideation is to be Undermined by one’s self.
To have experienced delusions,...
08/18/2014
Psych Congress Network
Blog
Distinguishing Bipolar Disorder From ADHD
05/07/2014
Although the diagnostic criteria for the two conditions seem distinctive at first glance, there is a significant degree of variability of symptom presentation.
Although the diagnostic criteria for the two conditions seem distinctive at first glance, there is a significant degree of variability of symptom presentation.
Although the diagnostic criteria...
05/07/2014
Psych Congress Network
Blog
To Live or Survive...That is the Question
03/18/2014
Help me to let go and Live, to bloom in resonance with the rest of our passionate universe. To see my own life as something sacred and not just a death sentence to serve until it is finally over.
Help me to let go and Live, to bloom in resonance with the rest of our passionate universe. To see my own life as something sacred and not just a death sentence to serve until it is finally over.
Help me to let go and Live, to...
03/18/2014
Psych Congress Network
Blog
How Dante and Virgil Can Guide Recovery From Mental Illness
02/21/2014
To truly recover, the questions surrounding survival become more basic, more fundamental, and less focused on a particular disorder. They become more about life.
To truly recover, the questions surrounding survival become more basic, more fundamental, and less focused on a particular disorder. They become more about life.
To truly recover, the questions...
02/21/2014
Psych Congress Network
Blog
Foundations of a Breakthrough: Building a Strong Therapist-Client Relationship
01/17/2014
The foundational piece in each part of my journey today has been my relationship with my treatment team. When treating a client, it is important to remember that you may be the only close relationship they have or can trust.
The foundational piece in each part of my journey today has been my relationship with my treatment team. When treating a client, it is important to remember that you may be the only close relationship they have or can trust.
The foundational piece in each...
01/17/2014
Psych Congress Network
Blog
Connecting With A Treating Clinician After Recovery
12/18/2013
Years after my time in the VA hospital, I had been asked to present back at the hospital in which I was once a patient. In the back row was an MD who seemed to be on the brink of tears. This was the doctor I thought was trying to kill me when...
Years after my time in the VA hospital, I had been asked to present back at the hospital in which I was once a patient. In the back row was an MD who seemed to be on the brink of tears. This was the doctor I thought was trying to kill me when...
Years after my time in the VA...
12/18/2013
Psych Congress Network
marc agronin md
Blog
Alzheimer Disease Prevention: Part 2
07/29/2024
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

Posters

Utilization of Psychiatric Pharmacogenomic Testing by Primary Care Physicians and Advanced Practice Providers: Confidence and Implementation Barriers
Routine implementation of pharmacogenomic testing for mental health and other conditions treated in primary care may require overcoming barriers such as cost to the patient and knowledge ...
10/26/2023
Valbenazine Improves Tardive Dyskinesia With or Without Concomitant Antipsychotic Therapy: A Meta-Analysis of Three Long-Term Valbenazine Trials
Valbenazine is indicated for once-daily treatment of tardive dyskinesia (TD), a movement disorder associated with prolonged antipsychotic exposure. Data from 3 long-term studies (KINECT™-...
10/26/2023
Veterans’ Intensive​ PCMHI Boot Camp​ (VIP Boot Camp)
Veterans Intensive Primary Care Mental Health Integration Bootcamp (VIP Bootcamp): An upstream solution to Mental Health(MH) access issues within the VA system
10/26/2023
Viloxazine ER (Qelbree®) Administered with Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Topline Results of a Phase IV Safety Trial
Results of a phase IV, open-label safety study evaluating viloxazine ER (Qelbree®) administered with psychostimulants in pediatric (6-17 years) ADHD; morning vs. evening administration of...
10/26/2023
Withdrawal Catatonia: A Rare Case of Treatment-Resistant Catatonia Secondary to Quetiapine Withdrawal
Catatonia is a psychomotor syndrome with well-defined clinical characteristics, although the neurological mechanisms involved remain unknown. In this study, we report a case of a patient ...
10/26/2023
Zuranolone Safety and Tolerability in Adults with Postpartum Depression: Analyses from SKYLARK, a 50 mg Placebo-Controlled Study
In the SKYLARK Study, zuranolone 50 mg was generally well tolerated in adults with postpartum depression; treatment-emergent adverse events (TEAEs) led to zuranolone dose reduction and di...
10/26/2023
Use Of VMAT2 Inhibitors For Tardive Dyskinesia In Geriatric Populations - A Case Study
This case report discusses the safety and efficacy of VMAT2 inhibitors in treating antipsychotic induced tardive dyskinesia in adults >55 years old. It also highlights the increased ri...
10/26/2023
Using Chess as a Novel Means to Cure Treatment Refractory Catatonia
The subject matter of the poster includes a case report of a patient with treatment refractory catatonia whose condition rapidly improved following a game of chess, one of the patient's k...
10/26/2023
Understanding the Real-World Prescription Patterns and Impact of Atypical Antipsychotic Augmentation Timing on Healthcare Cost in Adult Major Depressive Disorder in the United States: A Systematic Literature Review
This study examined the utilization pattern of augmentation with atypical antipsychotics after partial or no response to antidepressants in patients with MDD. The antidepressant prescript...
10/26/2023
Unique Features of the Rapid Mood Screener Enable Detection of Bipolar I Disorder in a Primary Care Practice
The Rapid Mood Screener (RMS) is a self-administered screening tool to help differentiate bipolar I disorder from major depressive disorder. Cases were identified from a primary care sett...
10/26/2023

Practice Tools

Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16)
09/30/2016
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to Use Quick Inventory of Depressive Symptomatology (Self-Report)  (QIDS-SR-16) has proven useful for many years as a way of determining a patient’s level of depression before, during, and after treatment. It is...
How to...
09/30/2016
Psych Congress Network
Saundra's Corner
Bipolar Spectrum Diagnostic Scale (BSDS)
09/28/2016
How to Use The Bipolar Spectrum Diagnostic Scale (BSDS) is a descriptive story that captures subtle features of bipolar illness. It does not provide a “yes” or “no” answer to whether or not a patient has bipolar disorder – it addresses the...
How to Use The Bipolar Spectrum Diagnostic Scale (BSDS) is a descriptive story that captures subtle features of bipolar illness. It does not provide a “yes” or “no” answer to whether or not a patient has bipolar disorder – it addresses the...
How to Use The Bipolar Spectrum...
09/28/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement